Intermountain Medical Center, Department of Internal Medicine, Murray, UT, United States of America.
Intermountain Medical Center, Department of Internal Medicine, Murray, UT, United States of America; University of Utah Division of General Internal Medicine, Department of Internal Medicine, Salt Lake City, UT, United States of America.
Thromb Res. 2018 Dec;172:54-60. doi: 10.1016/j.thromres.2018.10.013. Epub 2018 Oct 19.
Central venous catheters (CVC) and peripherally inserted central catheters (PICCs) are central vascular access devices (CVADs) that facilitate administration of medications among critically ill patients. Both are associated with risk of venous thromboembolism (VTE). The relative risk of VTE between these catheter types is not well defined. We report the rate of VTE in intensive care unit (ICU) medical patients receiving PICC, CVC, both, or neither.
We conducted a single-center, retrospective cohort study of medical-ICU patients between November 2007 and November 2013 grouped by receipt of CVC, PICC, both, or neither. The primary outcome was the rate of 30-day symptomatic venous thrombosis (upper and lower deep vein thrombosis and pulmonary embolism). Cox modeling was used to analyze this population and adjust for comorbidities which could contribute to VTE. Secondary outcomes included VTE location, major bleeding, and all-cause mortality among patients with and without CVADs.
We analyzed 5788 patients. CVADs were placed in 2403 (42%) patients (PICC, n = 816; CVC, n = 1153; both, n = 434). Compared with no CVAD, the hazard ratio (HR) for 30-day VTE was 1.81 (95% CI 1.52-2.17) for any CVAD, 1.90 (95% CI 1.52-2.37) for PICC, 1.57 (95% CI 1.26-1.96) for CVC, and 2.70 (95% CI 2.09-3.47) for both. PICCs had a non-significantly higher HR for VTE compared with CVC (1.21; 95% CI 0.94-1.55). For patients with both a CVC and PICC the HR for VTE was 1.72 times that of solitary CVAD (95% CI 1.32-2.23).
Among critically ill medical patients, PICCs and CVCs were associated with increased risk of VTE. Placement of both conferred higher risk of VTE compared with either alone.
中心静脉导管(CVC)和外周静脉置入中心导管(PICC)是中央血管通路装置(CVAD),可方便危重症患者给药。两者均与静脉血栓栓塞症(VTE)的风险相关。这些导管类型之间 VTE 的相对风险尚未明确界定。我们报告了在接受 PICC、CVC、两者或两者均未接受的重症监护病房(ICU)内科患者中 VTE 的发生率。
我们进行了一项单中心、回顾性队列研究,纳入了 2007 年 11 月至 2013 年 11 月期间 ICU 内科患者,根据是否接受 CVC、PICC、两者或两者均未接受分组。主要结局为 30 天内有症状的静脉血栓形成(上、下肢深静脉血栓形成和肺栓塞)的发生率。采用 Cox 模型分析该人群,并调整可能导致 VTE 的合并症。次要结局包括 CVAD 患者和无 CVAD 患者的 VTE 部位、大出血和全因死亡率。
我们分析了 5788 名患者。在 2403 名患者(42%)中放置了 CVAD(PICC,n=816;CVC,n=1153;两者,n=434)。与无 CVAD 相比,任何 CVAD 的 30 天 VTE 风险比(HR)为 1.81(95%CI 1.52-2.17),PICC 为 1.90(95%CI 1.52-2.37),CVC 为 1.57(95%CI 1.26-1.96),两者均为 2.70(95%CI 2.09-3.47)。PICC 与 CVC 相比,VTE 的 HR 无统计学意义更高(1.21;95%CI 0.94-1.55)。对于同时接受 CVC 和 PICC 的患者,VTE 的 HR 是单独接受 CVAD 的 1.72 倍(95%CI 1.32-2.23)。
在危重症内科患者中,PICC 和 CVC 与 VTE 风险增加相关。同时放置两者与单独放置相比,VTE 的风险更高。